Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice?
โ Scribed by J. Brouwer; R. de Bree; O.S. Hoekstra; J.A. Langendijk; J.A. Castelijns; C.R. Leemans
- Book ID
- 108705363
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 99 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1749-4478
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Purpose The aim of the study was to assess the interobserver variability in chest computed tomography (CT) and whole body 2-deoxy-2-[^18^F]fluoro-d-glucose positron emission tomography (FDG-PET) screening for distant metastases in head and neck squamous cell carcinoma (HNSCC) patients. ## Proce
Background. The aim of this study was to investigate the value of p53 and cyclin D1 gene expression in predicting the risk of occult lymph node metastases in patients with head and neck squamous cell carcinoma (HNSCC). Methods. The expression of cyclin D1 and p53 was evaluated by means of immunohis
Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this